Facial Nerve Articles & Analysis

1 news found

Neuraptive Therapeutics Announces FDA Clearance of a Second IND Application for NTX-001 in the Prevention of Postoperative Facial Paralysis and Plans to Initiate a Phase 2 Clinical Study Later This Year

Klebuc added, “We have put together a multi-centered group of physician-scientists who are eager to evaluate this new technology. The ability to fuse injured nerves and restore some degree of immediate function would be an incredible advancement in the treatment of facial nerve injuries. ...

Apr. 13, 2021

ByNeuraptive Therapeutics, Inc.

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you